Of note, our recent data also demonstrated that GSK-3β was not inhibited in Pdx1+/−/APP/PS1 mice, indicating that GSK-3β is not closely linked to chronic hyperglycemia-induced tau hyperphosphorylation [19]. This evidence concerns the gene MAPT and Hyperglycemia.